Benzoylecgonine (BZE) immunoassay reagent kits
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- N0018926DB001
- Awardee
-
Microgenics Corporation UEI E7WGWEK19Y79
- Awarding agency
-
Naval Supply Systems Command
Department of the Navy, Department of Defense
- Task orders
- 5 $51,557 obligated
Award facts
- Opportunity
-
- 6550 - BZE immunoassay reagent kits FFP IDIQ Pre-Solicitation Notice Pre-Solicitation · N0018925QZ583 · Posted Sep 25, 2025
- Combined order value
- $51,557 Current and potential, with all options
- Last date to order 13% complete
- IDV ceiling 7% used
- $775,453.50
- Maximum order
- $775,453.50
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- Funding agency
- Bureau of Medicine and Surgery Department of the Navy, Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
The Navy Bureau of Medicine and Surgery awarded a single-award indefinite-delivery contract to Microgenics Corporation on March 18, 2026, for benzoylecgonine (BZE) immunoassay reagent kits with a ceiling value of $775,453.50 and ultimate completion date of March 17, 2031. No set-aside was used.
The kits are designed to detect BZE in human urine samples using Beckman Coulter AU5800 series systems for drug screening and urinalysis testing of military and civilian personnel in testing-designated positions, supporting the Department of Defense Drug Demand Reduction Program. Work is performed at Microgenics' facilities in Fremont, California, with subordinate performance locations at San Antonio, Texas; Pomona, California; and military medical treatment facilities nationwide.
The originating solicitation, posted September 25, 2025, sought to procure the kits through an IDIQ with firm-fixed-price delivery orders under FAR Subpart 13.5 simplified procedures for commercial products on a best-value trade-off basis, with an ordering period spanning January 1, 2026, through December 31, 2030. The NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing); the PSC code is 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits and Sets).
One delivery order has been issued under this IDIQ: a $140 firm-fixed-price order awarded April 16, 2026, to the Navy Bureau of Medicine and Surgery for delivery to North Chicago, Illinois, with completion by September 30, 2026.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract N0018926DB001?
N0018926DB001 was awarded to Microgenics Corporation by Naval Supply Systems Command (Department of the Navy) on March 18, 2026.
How much is contract N0018926DB001 worth?
Orders under N0018926DB001 have obligated $51,557. N0018926DB001's own ceiling is $775,454. A single order can be worth up to $775,454.
How many orders have been placed under contract N0018926DB001?
5 orders have been placed under N0018926DB001, the latest on June 18, 2026.
Which agency awarded contract N0018926DB001?
Naval Supply Systems Command (Department of the Navy) awarded N0018926DB001, with funding from Bureau of Medicine and Surgery (Department of the Navy).
Who can order from contract N0018926DB001?
N0018926DB001 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract N0018926DB001 competed?
The extent of competition for N0018926DB001 was competed under sap. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV